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Neural repair after stroke involves initiation of a cellular proliferative program in the
form of angiogenesis, neurogenesis, and molecular growth signals in the surrounding
tissue elements. This cellular environment constitutes a niche in which regeneration of
new blood vessels and new neurons leads to partial tissue repair after stroke. Cancer
metastasis has similar proliferative cellular events in the brain and other organs. Do
cancer and CNS tissue repair share similar cellular processes? In this study, we identify
a novel role of the regenerative neurovascular niche induced by stroke in promoting
brain melanoma metastasis through enhancing cellular interactions with surrounding
niche components. Repair-mediated neurovascular signaling induces metastatic cells
to express genes crucial to metastasis. Mimicking stroke-like conditions in vitro displays
an enhancement of metastatic migration potential and allows for the determination of
cell-specific signals produced by the regenerative neurovascular niche. Comparative
analysis of both in vitro and in vivo expression profiles reveals a major contribution
of endothelial cells in mediating melanoma metastasis. These results point to a
previously undiscovered role of the regenerative neurovascular niche in shaping the
tumor microenvironment and brain metastatic landscape.
Keywords: angiogenesis, stroke, neuroblast, astrocytosis, gliosis
INTRODUCTION
In both health and disease, cellular interactions in the brain occur around a neurovascular niche of
neurons, endothelial cells, astrocytes, and stromal cells that maintain blood–brain barrier function
and neuronal signaling. Injury to this neurovascular niche during stroke elicits spontaneous but
limited repair processes that drastically alter the local environment: creating a cellular niche for
tissue repair. Immature neurons (neuroblasts) derived from neural stem cells in the subventricular
Frontiers in Neuroscience | www.frontiersin.org 1 April 2019 | Volume 13 | Article 297
fnins-13-00297 April 8, 2019 Time: 7:56 # 2
Prakash et al. Shared Cancer and Regenerative Niches in the Brain
zone migrate to injured brain regions and differentiate into
neurons. These migrating neuroblasts tightly associate with
the angiogenic vasculature, which secretes factors essential
to post-stroke neurogenesis (Ohab and Carmichael, 2008;
Lindvall and Kokaia, 2015). Reactive astrocytes and microglia
interact extensively with neuroblasts during post-stroke
neurogenesis and engage in signaling via cytokines and
growth factors to mediate several parallel cellular functions
after stroke, including increased angiogenesis (Ohab and
Carmichael, 2008; Lindvall and Kokaia, 2015). Because these
cellular elements collectively mediate repair after stroke
through angiogenesis, neurogenesis, and tissue reorganization,
this microenvironment has been termed the regenerative
neurovascular niche (Brumm and Carmichael, 2012).
Brain metastasis presents analogous features with these
regenerative neurovascular processes after stroke. In stroke tissue
repair, neuroblast migration from a distant brain region into
the regenerative neurovascular niche after stroke resembles the
migration and localization of a metastatic cancer cell within
the brain. Angiogenesis is an essential process in both brain
metastasis and repair after stroke (Fukumura et al., 2010; Ergul
et al., 2012). Reactive astrocytes interact with both neuroblasts
and metastatic cells, and are essential in promoting neurogenesis
and metastasis (Klein et al., 2015).
Compelling evidence suggests that similar signaling pathways
regulate both stroke repair and brain metastasis (Yao Y. et al.,
2016). Tumor suppressor phosphatase tensin homolog (PTEN)
is commonly mutated in cancers, and PTEN loss activates
oncogenes that reprogram the tumor microenvironment and
lead to the formation of brain metastasis. PTEN inhibition after
stroke promotes axon regrowth and neuronal repair (Bronisz
et al., 2011; Song et al., 2012; Wikman et al., 2012; Zhang et al.,
2015). VEGF and angiopoietin signaling mediate endothelial
cell proliferation and migration in both cancer metastasis and
neural repair after stroke (Hansen et al., 2008; Yang et al.,
2010; Ziyad and Iruela-Arispe, 2011; Lange et al., 2016). Matrix
metalloproteases (MMPs) also have dual roles in their proteolytic
activity, promoting cancer migration and invasion and enhancing
angiogenesis after stroke (Lutsenko et al., 2003; Ben-Baruch,
2008; Noel et al., 2008; Izraely et al., 2010; Gialeli et al., 2011;
Weitzenfeld and Ben-Baruch, 2013). The TGF-β system regulates
cancer cell proliferation in a context-dependent manner (Yang
et al., 2008) and mediates tissue reorganization and recovery
after stroke (Li et al., 2015). These studies suggest significant
overlap in signaling mechanisms of cancer metastasis and tissue
repair after stroke.
In short, while the processes of tissue regeneration and
metastasis have essentially opposite functional outcomes, the
niche components that drive them share similar cellular and
molecular features. Both the metastatic tumor and regenerative
neurovascular niches involve signaling among a principal cell
type (the cancer cell or neuroblast), angiogenic vasculature,
reactive astrocytes, and stromal cells. Based on the parallel
biology between these two disease processes we asked: (a)
could the regenerative neurovascular niche in stroke create
a facilitative substrate for brain metastasis, (b) could the
synergy between tissue repair processes and metastasis enhance
metastatic cell-niche interactions, and (c) does the presence
of repair-mediated neurovascular signaling alter the metastatic
transcriptome to enhance metastasis?
MATERIALS AND METHODS
Cell Culture
Human brain metastatic melanoma cells YDFR-CB3 were
generated in the Witz laboratory as described earlier (Izraely
et al., 2012; Klein-Goldberg et al., 2013). YDFR-CB3 cells
were cultured in RPMI medium supplemented with 10% heat-
inactivated fetal calf serum, 2 mmol/mL L-glutamine, 0.01M
HEPES buffered saline, 100 units/mL penicillin, 0.1 mg/mL
streptomycin, and 12.5 units/mL nystatin. The YDFR-CB3
cells were transduced with GFP virus (pCDH10-EF1-MCS-2A-
copGFP) (Boiko et al., 2010; Quintana et al., 2012). To produce
mCherry expressing cells, melanoma cells were transduced with a
pQCXIN-mCherry plasmid and selected using 800 µg/mL G418
Sulfate (A.G. Scientific, Inc., San Diego, CA, United States).
Immortalized human brain microvascular endothelial cells (hEC)
were kindly provided by Dr. Clara Nahmias and Prof. Pierre-
Olivier Couraud (Inserm, U1016, Institut Cochin, Paris, France;
Cnrs, UMR8104, Paris, France; University Paris Descartes,
Paris, France). hEC cells were cultured on collagen type I,
rat tail (1:30; BD Biosciences, Bedford, MA, United States) in
EBM-2 medium (Clonetics, Cambrex BioScience, Wokingham,
United Kingdom) supplemented with 5% heat-inactivated FCS,
2 mmol/mL L-glutamine, 100 units/mL penicillin, 0.1 mg/mL
streptomycin, 12.5 units/mL nystatin, 1 ng/mL basic FGF, 10 mM
HEPES buffered saline and 1.4 µM hydrocortisone. Human
astrocytes (HA; ScienCell Research Laboratories, Carlsbad, CA,
United States) were cultured on 0.0015% poly-L-lysine (Sigma-
Aldrich, St. Louis, MO, United States) in astrocyte growth
medium (AM, ScienCell Research Laboratories) supplemented
with 2% heat-inactivated FCS. Cells were routinely cultured in
humidified air with 5% CO2 at 37◦C.
Modeling Stroke and Metastasis
All animal procedures were carried out in accordance with the
National Institutes of Health animal protection guidelines and
protocols approved by University of California, Los Angeles
Chancellor’s Animal Research Committee. NOD-scid gamma
(NSG), a highly immunodeficient mouse model lacking T cells,
B cells, and NK cells, was used for these studies (Jackson
Laboratories). Inducing strokes in this immunodeficient mouse
strain provides a mouse model that allows for the engraftment
of human cancer cells without graft rejection and little to no
involvement of innate or acquired immunity (Agliano et al., 2008;
Chen Q. et al., 2009).
Ischemic strokes were induced in adult male NSG mice aged
2–4 months. Briefly, animals were anesthetized under 2.5–3%
isoflurane and positioned on a stereotactic apparatus (Model
940, David Kopf Instruments). To expose the skull, a midline
incision was made followed by a transverse incision above the
zygomatic arch. A craniotomy was performed to expose the
left middle cerebral artery (MCA). The proximal branch of
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the MCA was cauterized followed by bilateral occlusion of the
jugular veins for 15 min. Body temperature was maintained
at 37 ± 0.5◦C throughout the procedure (RightTempTM, Kent
Scientific, Torrington, CT, United States) as measured using a
rectal probe. After cauterization, the skin was glued together
to cover the skull and animals were returned to their home
cages for recovery. Metastasis was modeled by injecting YDFR-
CB3GFP+ cells (106 cells/50 µl of L15 medium) intracardially 7
days after stroke when the course of regeneration/tissue repair
by means of angiogenesis and neurogenesis had reached peak
activity (Ohab et al., 2006; Lamanna, 2012). On day 14 after
stroke, animals were euthanized and the brains were processed
for further experiments.
Sham surgeries were not performed. But surgical incision
areas were examined for any tumor homing and no metastasis
was observed in these regions.
Quantitative Analysis of Distribution of
Metastasis
Two cohorts consisting of six to eight male NSG mice each were
utilized to quantify the distribution of metastasis in different
brain regions. One cohort of animals was subjected to stroke
and metastasis and the other with metastasis alone. Brains were
extracted, fixed in 4% paraformaldehyde and cryosectioned into
100 µm thick sagittal sections while frozen in OCT. Four sections
per animal were used to quantify metastasis and the distribution
of YDFR-CB3GFP+ cells in various brain regions. Sections were
imaged, outlined, and GFP+ cells were manually counted using a
stereoinvestigator (StereoInvestigator MBF Bioscience, Williston,
VT, United States) on a Leica DMLB fluorescent microscope
(Leica Microsystems, Wetzlar, Germany) with a 40× objective.
Immunohistochemistry and Confocal
Imaging
Immunohistochemistry was performed on free-floating brain
sections. Briefly, entire extracted brains were fixed in 4%
paraformaldehyde for 24 h and then cryoprotected in 30%
sucrose for 48 h. After cryosectioning, 50 µm thick sagittal
sections were washed 3× with PBS (phosphate buffered saline)
and blocked with 2% horse serum and 5% normal donkey
serum in 0.3% Triton. The primary antibodies used are goat
anti-DCX (Santa Cruz Biotechnology, CA); rat anti-PECAM
(BD Pharminogen); rat anti-GFAP (Invitrogen, IL); Rb anti-
albumin (Genetex, CA); mouse anti-MART-1 (Novus biologicals,
CO); Rb anti-Tuc-4 (EMD Millipore, CA); mouse antiPSA-
NCAM (Millipore, CA); Isolectin Dylight 649 (Vector labs,
CA). Sections were incubated with primary antibodies overnight
followed by 3× wash with PBS. Secondary antibodies were
tested without primary antibodies for non-specific binding were
negative (data not shown). Sections were stained with respective
secondary antibodies, incubated for 1 h, and washed 3× with
PBS. The stained sections were mounted on slides, dehydrated
and coverslipped.
For the time course experiments assessing cellular
relationships, GFAP, DCX, and lectin immunoreactive areas
around the peri-infarct region were imaged. Images were
captured of three fields at 100× for astrocytes and 40× for
neuroblast and vasculature from three independent sagittal
sections of each animal on a confocal microscope (Nikon
C2). Z-stacked images of size 512 × 512 were captured.
Scanning parameters were maintained constant across groups
for consistency.
Human brain metastatic melanoma tissues excised from
patients were used to assess neurovascular associations with the
metastatic melanoma cells. Paraffin-embedded, slide-mounted
human brain sections (5 µm thick) were first immersed
in water at 85◦C and washed three times, de-paraffinized
and hydrated. Double antigen retrieval was performed first
using Sodium citrate pH 6 followed by EDTA at pH 8
for 25 min each. As outlined above, immunohistochemistry
was performed with MART-1, Tuc-4, and GFAP to identify
melanoma cells, neuroblasts and astrocytes, respectively. The
Tuc-4, DCX, and GFAP stains were optimized on human
hippocampus sections prior to staining the human brain
metastatic melanomas.
Microsphere Injections and Analysis
Blood–brain barrier leakage and melanoma extravasation
were tested with an intracardiac injection of 100 µl of
0.2-µm diameter yellow–green polystyrene fluorescent
microspheres (Molecular Probes) which are relatively smaller
than metastatic melanoma cells in NSG mice 1 and 7 days
after stroke. The microspheres were allowed to circulate for
8 min and the animals were euthanized and brains extracted
for immunohistochemistry. 100 µm thick sections were
immunostained for the vasculature using PECAM and
imaged with Nikon C2 confocal microscope. Intravascular
microsphere volume was analyzed (Volocity Improvision 5.5).
On the 3D rendered image PECAM positive regions were first
detected and selected then regions outside of the PECAM were
cropped and the volume of GFP+ microspheres accumulated
inside these PECAM vessels within the peri-infarct and
corresponding contralateral regions was quantified. Schematics
are shown in Figure 1J.
In vivo Hypoxia Model
NOD-scid gamma mice were housed for 7 days in a
hypoxic chamber (Coy Laboratory Products, Grass Lake,
MI, United States) maintained with a continuous flow of
10% O2 mixed with N2 as background gas. Chamber O2
concentration was checked daily and CO2 was eliminated by
refurbishing the hypoxic chamber with fresh O2. Humidity
from respiration was controlled with silica desiccant. Animals
were provided with food and water ad libitum throughout
the experiment. After 7 days of hypoxia exposure, YDFR-
CB3GFP+ cells (106 cells/50 µl of L15 medium) were
intracardially injected. The animals were then housed in
normoxia/ambient Oxygen levels until day 14. The animals were
then euthanized and the brain extracted to analyze the metastatic
response to hypoxia-mediated angiogenesis (Harik et al., 1996;
Tarnawski et al., 2014).
Frontiers in Neuroscience | www.frontiersin.org 3 April 2019 | Volume 13 | Article 297
fnins-13-00297 April 8, 2019 Time: 7:56 # 4
Prakash et al. Shared Cancer and Regenerative Niches in the Brain
Quantitative Analysis of Cellular
Associations
Neurovascular associations with melanoma were assessed using
DCX-RFP reporter mice. These mice were immunosuppressed
with IP injections of Tacrolimus-FK-506 (Cell Signaling,
Danvers, MA, United States) beginning with a daily
intraperitoneal injection of Tacrolimus (3 mg/kg/day; dissolved
in DMSO) 2 days prior to stroke and continuing until the
mice were euthanized. The extracted whole brains were
fixed, permeabilized, and cryosectioned into 50 µm thick
sections. Cell-specific antibodies identified each of these
cell types (neuroblasts, astrocytes, and vasculature) through
immunohistochemistry.
The cellular association of brain metastatic melanoma with
the cells in the regenerative neurovascular niche was assessed
by measuring the distances between individual components
(astrocytes, neuroblasts) and YDFR-CB3GFP+ cells using Imaris
software version 8.3.1 (Bitplane R©). Inflection point analysis and
melanoma distance to vascular segments were measured using
Volocity Improvision 6. Inflection point measures the number
of irregularities within a curvature or change in direction of
curvature (Bullitt et al., 2003, 2007). Inflection point ratios
were obtained by counting the number of nodes on a vascular
segment associated with a metastatic foci and normalizing it to
a distant vasculature from the same animal. Vascular segments
of the same linear length were compared for every observation
for consistency.
In vitro Oxygen Glucose Deprivation
(OGD) and Generation of Conditioned
Medium
An oxygen-glucose deprivation (OGD) treatment of brain
microenvironmental cells was used as an in vitro model for
stroke (Yang et al., 2012). 5 × 105 human brain endothelial cells
and astrocytes were seeded for 24 h. Then, cells were washed
with PBSX1 and culture medium was replaced with 0.5% FCS
supplemented DMEM medium lacking glucose. The cells were
incubated in a hypoxia chamber (Hot box; Billups-Rothenberg
Inc, Del Mar, CA, United States) with a gas mixture of: 1% O2,
5% CO2, and 94% N2 for 4 h in 37◦C. Cells in control group
were treated with 0.5% FCS supplemented DMEM medium with
normal glucose levels. These cells were incubated in normoxia for
4 h in 37◦C.
Following hypoxia or normoxia, both OGD and control
culture media were replaced with a suitable 0.5% FCS
supplemented medium (EBM2 for endothelial cells or AM
for astrocytes) and incubated in normoxia for 20 h in 37◦C,
to simulate the reperfusion phase following stroke. Finally,
conditioned media from control and OGD cultures was collected,
centrifuged and filtered (0.45 µm; Whatman GmbH, Freiburg,
Germany) on ice.
Viability Assay
To examine cell viability of astrocytes and BECs subjected to the
OGD treatment, 5 × 103 cells were seeded overnight in coated
96 well-tissue plates. Cells were washed once with PBSX1 and
exposed to OGD treatment or normoxia for 4 h with 100 µl
relevant DMEM starvation medium. In these studies, AM is
astrocyte medium (cat. no. 1801 ScienCell Research Laboratories)
and EBM2 is Endothelial Cell Growth Basal Medium-2 (cat. no.
00190860 Lonza). After 4 h the medium was replaced with EBM-2
or AM containing 0.5% serum. Cell viability was determined after
44 h by using Cell Proliferation Kit (XTT, Biological industries,
Kibbutz Beit Haemek, Israel), according to the manufacturer’s
instructions. Absorbance at 450 nm (OD450) was determined for
each well using an automated microplate reader (SpectraMax
190; Molecular Devices, Sunnyvale, CA, United States) and
subtraction of non-specific readings (measured at 630 nm) was
done automatically during the OD450 reading.
Adhesion Assay
Approximately 5 × 104 brain endothelial cells were cultured
overnight to form a confluent monolayer, then washed with
PBSX1 and subjected to OGD or normoxia for 4 h with 100 µl
relevant DMEM starvation medium. After 4 h, the medium was
replaced with 100 µl EBM-2 starvation medium containing 0.5%
FCS (EC starvation medium) for 20 h.
At the end of the reperfusion phase to model what happens
in the in vivo setting, brain endothelial cells, in vitro were gently
washed twice with PBSX1. 1 × 105 m-Cherry labeled melanoma
cells diluted in TBSX1 (Tris-buffered saline) containing 2 mM
CaCl2 were added onto the endothelial monolayer and incubated
for 30 min at 37◦C to allow adhesion to occur. The total
fluorescence signal of labeled cells added to the well before the
removal of the non-adherent cells was measured by a fluorescent
microplate reader (BioTek FL500, BioTek Instruments, Inc.,
Winooski, VT, United States) at wavelength of 490/530. Then,
the wells were washed three times with PBSX1 to remove
non-adherent cells and fluorescence of the adherent cells was
measured at wavelength of 490/530. To obtain the percentage of
adherent cells, the ratio between the OD of the adherent cells and
that of the total cells plated was calculated and multiplied by 100.
To determine VCAM-1 involvement, 5 µl/mL VCAM-1 blocking
antibody (BD PharmingenTM, San Diego, CA, United States) was
added to the m-Cherry labeled melanoma cells that were added
onto the endothelial monolayer following the OGD treatment.
ECM Transmigration Assay
About 5× 104 brain endothelial cells or astrocytes were cultured
overnight. Cells were washed once with PBSX1 and subjected
to OGD treatment or normoxia for 4 h with relevant DMEM
starvation medium. After 4 h, the medium was replaced with
EBM-2 starvation medium for endothelial cells or AM starvation
medium containing 0.5% FCS for astrocytes for 20 h. Transwell
inserts (6.5 mm diameter polycarbonate membrane with 8.0 µm
pores, Corning Costar Corp., New York, NY, United States) were
coated with 100 µg/mL collagen type I for 1 h at 37◦C. After two
washes with 200 µl PBSX1, 1 × 105 melanoma cells were added
to the Transwell for 1.5 h at 37◦C, and the cells were allowed
to settle on the semipermeable membrane of the Transwell. The
Transwells were placed in the well plates containing the OGD
or control endothelial cells or astrocytes and melanoma cells
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were allowed to transmigrate through the ECM (Collagen) and
membrane overnight toward the lower chamber.
At the end of the migration period, melanoma cells in the
upper chamber that had not transmigrated were removed using
cotton swabs, followed by a gentle wash of the bottom side
of the Transwell inserts in PBSX1 and fixation in absolute
methanol for 5 min. The Transwell inserts were washed in PBSX1
and stained with Diff-Quik R© staining kit (Medion Diagnostics,
Düdingen, Switzerland).
Transwells were photographed using Olympus IX53 inverted
microscope fitted with an Olympus DP73 camera Olympus
Inc., Hamburg, Germany), two fields per Transwell in duplicate
Transwells. Cells per field were counted or analyzed using
ImageJ software.
Cytokine Array
The supernatants from OGD and control astrocytes
and endothelial cells were analyzed for the secretion of
102 cytokines, using the Proteome Profiler Human XL
Cytokine Array Kit (R&D systems, Inc., Minneapolis, MA,
United States), according to the manufacturer’s instructions.
A minimum of a 20% difference in pixel density between
OGD and control samples was accounted as a change in
secretion level.
Tissue Processing and FACS
Male NSG mice aged 2–4 months were subjected to stroke
followed by metastasis at day 7 as previously described.
To eliminate any confounding factors and since estrogen is
neuroprotective, male animals were used for this study. On day
14 after stroke, the animals were anesthetized with isoflurane,
decapitated, and the peri-infarct areas were carefully dissected
using a sterile lancet. Corresponding areas dissected from
the non-stroke side served as a control. The dissected tissue
was further cut into fine bits with a sterile blade, triturated
with a pipette tip, and digested in 3 mL of collagenase
(3 mg/mL, Roche Diagnostics) at 37◦C for 25 min at 170 rpm.
Hibernate buffer without calcium (Brainbits, Springfield, IL,
United States) was used to maintain tissue viability and pH
during the process of dissection and digestion. The digestate
was triturated and washed twice at 3,000 rpm for 10 min
with this hibernate medium. To enrich the human population
and deplete potential mouse cells from the neural tissue, the
pellet was re-suspended in low fluorescence hibernate media
and the MACS- mouse cell depletion kit (Miltenyi Biotec,
San Diego, CA, United States) was used as per manufacturer’s
instructions. Brain metastatic melanoma cells were negatively
selected through immunomagnetic separation as provided by the
manufacturer’s protocol.
The enriched cell suspensions were stained with melanoma
marker MCSP conjugated with PE (Human; MCSP-PE,
10 µL antibody/107 cells, Miltenyi Biotec, San Diego, CA,
United States) by incubation at 4◦C for 10 min. The cells
were washed with 2 mL of Hibernate medium, re-suspended
in low fluorescence hibernate medium, and maintained on
ice during FACS isolation. Cell were co-stained with DAPI
to sort for live cells. DAPI, PE, and GFP gates were set using
positive and negative controls prior to sorting melanoma
cells. Metastatic melanoma cells were collected via FACS
(FACsARIA, Becton Dickinson, UCLA FACS Core) into low
fluorescence medium.
RNA Isolation (Both in vivo and in vitro)
FACS-sorted cells were pooled from six to eight animals
and the RNA was extracted using an RNA-Microprep kit
(Zymo-Research) and eluted into 12 µL RNAse-free H2O.
RNA-quality was verified on an Agilent Bioanalyzer using
an Agilent picokit with relative concentrations that ranged
from 170 to 1,733 pg/µL. Samples with RIN > 6 were sent
for sequencing. For the extraction of RNA from in vitro
melanoma cultures, YDFR-CB3 cells were treated with
conditioned media of either OGD or normoxic conditions
on hEC/h-Astro. Melanoma cells were then washed twice
with PBSX1 and RNA was extracted using the NucleoSpin
miRNA kit (Macherey-Nagel, Düren, Germany) according to the
manufacturer’s instructions.
RNA Sequencing and Transcriptome
Analysis
RNA sequencing was done by the UCLA Neuroscience Genomics
Core at UCLA. Briefly, for in vivo samples, library was prepared
using Ovation RNA Ultra Low Input (500 pg) kit (Nugen
manufacturer) and TruSeq Nano DNA library preparation kit
(Illumina manufacturer). Amplified cDNA was purified and
validated followed by library preparation. Preparation included
69 bp paired end reads. Samples were sequenced by Hi-Seq 2500
over 7 RapidRun lanes, corresponding to about 1.8 samples per
lane (80 million reads per sample) for the in vivo datasets. In vitro
samples were sequenced over 12 RapidRun lanes, corresponding
to about 2.3 samples per lane (65 million reads per sample).
RNA sequencing performed on melanoma cells conditioned
with either astrocyte/endothelial (OGD/control) conditioned
media resulted in 60,906,978 to 25,890,188 with 40.18 to 75.37%
of uniquely mapped reads. Samples with a minimum of 10
transcript counts were used and κ = 3 for in vitro batch correction
was applied in edgeR package. Melanoma cells exposed to
endothelial conditioned media with or without OGD resulted in
4717 significant DE (differentially expressed) genes (p < 0.05).
Further filtering for log2 (fold change) ≥ ±0.5 resulted in
3,073 genes of which 712 were upregulated and 2,361 were
downregulated. Melanoma cells exposed to astrocyte conditioned
media with or without OGD resulted in 1,127 significant DE
genes (p < 0.05). Further filtering for log2 (fold change) ≥ ±0.5
resulted in 362 genes of these, 252 were upregulated and 111
were downregulated.
Read Mapping, Assembly, and
Expression Analysis
Short reads were aligned using STAR to the latest human
reference genome (GRCh38). Fragment counts were determined
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by HTseq program using RefSeq gene and Ensembl transcript
model (Conesa et al., 2016).
Differentially Expressed (DE) Gene
Analysis Between in vivo and in vitro
Datasets
Due to the large number of samples, unexpected batch effects
were expected. Removal of unwanted variation (RUV) is
effective to remove such batch effect. For in vitro datasets, raw
counts were filtered (minimum 10 counts for at least eight
samples), and then normalized by TMM followed by RUV
correction with k = 3 (Risso et al., 2014). Differentially expressed
genes were determined using edgeR. For in vivo samples,
differential expression analysis was done without RUV correction
(Robinson et al., 2010).
GSEA (Gene Set Enrichment Analysis)
Within this analysis, a hallmark gene set is defined by a
collection that summarizes specific well-defined biological
states, processes, or diseases with coherent expression
changes in many molecules within a system (Subramanian
et al., 2005; Liberzon et al., 2015). A unique Stroke-MET
transcriptome was identified by subtracting metastatic
melanoma gene expression in non-stroke vs. metastatic
melanoma gene expression in the stroke side. The set of
differentially regulated genes in the Stroke-MET transcriptome
were probed for common regulatory elements, which might
be controlling gene expression. These are termed upstream
regulators, as they are predicted to regulate genes that are
significantly induced or downregulated in the Stroke-MET
transcriptome. These upstream regulators were tested for
significance based on an enrichment score (Fisher’s exact test
p-value overlap of predicted and observed regulated gene
sets) and activation Z-scores (to test for their association
with up or down-regulation of their associated genes) in the
Stroke-MET transcriptome.
Network Generation and Properties
To explore the molecular interactions, transcription profiles that
overlap between in vivo and in vitro datasets were analyzed.
Overlapping molecular transcription profiles between in vivo
and in vitro datasets with high focus numbers were analyzed
for network properties. Network properties such as degree
and betweenness centralities were assessed with CytoNCA
(Tang et al., 2015).
SPIA (Single Primer Isothermal
Amplification)
To further validate candidate gene expression profiles obtained
from the RNAseq datasets, metastatic melanoma cells were FACS
isolated as described above from independent experimental
samples. The resultant RNA were in pg/µl range and
this was amplified using the Nugen Ovation R© Pico WTA
System V2. RNA amplification was performed based on
the protocol and instructions provided in the kit using the
Ribo-SPIA technology.
qPCR Analysis of Molecules Associated
With Both the Metastatic
Microenvironment
The SPIA amplified RNA were used to test the gene expression
fold change between the metastatic melanoma cells associated
with the stroke and non-stroke sides of the brain. 1.25 ng/µl
of cDNA was generated from each sample and used to detect
expression using Roche Light Cycler 480 SYBR Green I Master
Kit. RT-qPCRs were performed using custom primers and
human-GAPDH as the house keeping gene.
CLARITY (Clear Lipid-Exchanged
Acrylamide-Hybridized Rigid Imaging
Compatible Tissue Hydrogel)
Brains exposed to both stroke and metastasis in DCX-RFP mice
were extracted. Brains were left intact and were optically cleared
using a CLARITY-PACT protocol modified for passive and quick
clearing (Chung and Deisseroth, 2013; Tomer et al., 2014; Yang
et al., 2014). Briefly, each DCX-RFP animals subjected to stroke
and metastasis were perfused with 100 µl of vascular lectin
(Vector Laboratories) prior to euthanization. The brains were
then fixed with 4% paraformaldehyde and incubated at 40◦C with
30 mL of cold hydrogel for 5 days. Prior to polymerization of the
hydrogel, the tubes were vacuum sealed, purged with nitrogen
gas and immediately sealed. The tubes were then incubated
at 370◦C for 4–5 h to allow for adequate polymerization of
the hydrogel bound tissue. After polymerization, excess gel was
carefully removed and the whole brain was cut into 2 mm thick
sagittal sections using a brain mold. The brains were passively
cleared with a solution of 200 mM boric acid, 8% SDS, pH 8.5
at 400◦C. Clearing solution was refreshed every day until the
sections were transparent. The tissue sections were rinsed with
PBS and mounted in Focus Clear (CelExplorer Labs, Hsinchu,
Taiwan) solution. The sections were imaged under a confocal
microscope (Nikon C2) at 10× and the stacked images were
constructed into video files.
Statistical Analysis
Data analysis was done with Microsoft Excel and GraphPad
Prism version 7.00 (GraphPad Software, La Jolla, CA,
United States). Statistical significance was determined by
two-tailed unpaired Student’s t-test when comparing two groups,
one-way ANOVA, or two-way ANOVA wherever appropriate
for experiments consisting of more than two groups. Disease
and time course interaction and effects were done followed with
post hoc test with wither Holm-Sidak or Fisher’s least significant
difference (LSD) and are specified on each figure legends.
Significance values are presented as mean ± standard error of
the mean (SEM) for the in vivo experiments and mean ± SD for
the in vitro experiments.
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RESULTS
The Regenerative Neurovascular Niche
Enhances Melanoma Brain Metastasis
NOD-scid gamma mice were subjected to distal middle cerebral
artery occlusion (MCAo), a common, clinically relevant stroke
model (Agliano et al., 2008; Chen B. et al., 2009), and injected
with YDFR-CB3, a melanoma line selected for its ability to
form brain macrometastases (Izraely et al., 2010). This is an
ideal model to test the preferential localization of a metastatic
tumor cell, since melanoma develops from the neural crest and
commonly metastasizes to brain (Boiko et al., 2010; Izraely
et al., 2012; Quintana et al., 2012; Marzese et al., 2015). YDFR-
CB3GFP+ were administered via intracardiac injection 7 days
post-stroke, when angiogenesis and neurogenesis peak and the
regenerative neurovascular niche is most active (Morris et al.,
2003; Ohab et al., 2006; Lamanna, 2012). The total number
of metastatic cells in the brain was significantly greater in
the stroke group compared to controls 7 days post-injection
(p = 0.0082, control metastasis 245 ± 57, stroke + metastasis
653 ± 122) (Figures 1A–C and Supplementary Figure 1). The
YDFR-CB3GFP+ cell distribution was quantified in the peri-
infarct, where angiogenic vessels are predominantly found, and
in other brain regions in which angiogenesis or tissue repair
is absent (Cavaglia et al., 2001): periventricular white matter,
striatum, hippocampus, and olfactory bulb. On average, 433± 67
YDFR-CB3GFP+ cells preferentially localized to the peri-infarct
compared to other regions in stroke and 73 ± 23 cells were
found in corresponding cortical regions in control metastasis
(p = 0.0012, n = 6–7) (Figure 1D). This data indicates that
metastatic melanoma preferentially localizes to the regenerative
neurovascular niche.
Metastasis to the Regenerative
Neurovascular Niche Occurs
Independently of Hypoxia Mediated
Angiogenesis
Within the regenerative neurovascular niche after stroke,
there are several potential cellular signaling sources that
might influence brain metastasis. Angiogenic endothelial cells
may directly initiate melanoma cell localization and establish
metastasis. Instead, melanoma cells may localize to the
regenerative multicellular environment of endothelial cells,
astrocytes and neuroblasts within the peri-infarct cortex, the
combination of these cells constituting a niche in which cell–
cell communication is the interaction of the cells (the niche)
rather than that of a single cell (Carmichael, 2016). To test
this, we used a model of global angiogenesis that does not
produce the regenerative neurovascular niche or neurogenesis
seen in stroke. Chronic hypobaric oxygen mediates angiogenesis
by globally increasing cerebral vascular density (Figures 1E,F)
(Harik et al., 1996; LaManna et al., 1998). If angiogenesis
itself is inducing melanoma cell localization, this generalized
angiogenic state would be expected to result in the preferential
localization of vascular melanoma cells. A cohort of hypoxic
animals subjected to 10% hypoxia for 7 days was injected with
metastatic melanoma cells intracardially and the number of
metastatic foci was assessed 7 days after injection. Each metastatic
focus represents an incidence of metastasis and is defined by
a cluster of melanoma cells that has localized and developed
into a colony. The 62 ± 6 metastatic foci observed in the
peri-infarct region was significantly higher than 36 ± 4 of the
hypoxic cohort (p = 0.003, n = 6–8) (Figure 1G). This suggests
that the regenerative response after stroke significantly enhances
brain metastasis localization of melanoma compared to hypoxia-
mediated angiogenesis alone.
Metastasis to the Regenerative
Neurovascular Niche Occurs
Independently of Vascular Hemodynamic
Changes
Stroke alters blood flow dynamics and blood–brain barrier
permeability in the peri-infarct tissue (Chen Q. et al., 2009) into
which metastatic melanoma preferentially localize. To investigate
whether this preferential localization of melanoma is simply
due to the alterations in blood flow or vascular permeability
changes induced by stroke, we injected two cohorts of animals
with fluorescent microspheres (0.2 µm diameter) at 1 and 7
days after stroke. These microspheres lodge in the capillary
bed and allow for tracking and quantification of differences in
blood flow to different brain regions (Springer et al., 2000).
The volume of microspheres accumulated in angiogenic vessels
within the peri-infarct and corresponding contralateral regions
was quantified. No significant difference was observed between
microsphere accumulation in the ischemic and non-ischemic
hemispheres at days 1 and 7 after stroke (Figures 1H–J). This
suggests that blood flow to the peri-infarct is not significantly
altered at these time periods after stroke and that blood flow
changes are not the cause of the observed preferential melanoma
cell metastasis to this region.
Vascular leakage due to blood–brain barrier breakdown leads
to extravasation of plasma proteins (Abraham et al., 2002;
Tenreiro et al., 2016). To determine if blood–brain barrier
permeability changes could contribute to preferential localization
of melanoma, we stained brain sections for endogenous albumin
extravasated at days 1 and 7 after stroke (Abraham et al.,
2002). The mean intensity of extravascular albumin was elevated
at day 1, but significantly reduced at day 7 and was not
different from the corresponding contralateral region at day 7
(p = 0.0255, n = 5) (Figures 1K,L). These findings support
the idea that the localization of metastatic melanoma cells to
the peri-infarct at day 7 are not due to vascular hemodynamic
changes induced by stroke, and may be due to specific cellular
or molecular features of these vessels within the angiogenic
neurovascular niche.
Neuroblast-Associated Vessels Within
the Regenerative Neurovascular Niche
Mediate Brain Metastasis
Intercellular communication between cancer cells and host tissue
is critical for metastatic localization and tumor progression
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FIGURE 1 | The regenerative neurovascular niche after stroke facilitates brain metastasis. (A) Representative brain images from control and stroke groups subjected
to melanoma metastasis shown in the top panel. GFP+ cells identifies brain metastatic melanoma at high magnification in the bottom panel. (B) Schematics showing
region from stroke brains and corresponding regions in control quantified. (C) Bar graphs of total number of metastatic cells in both control and stroke groups and
(D) showing quantification and distribution of metastatic cells in different brain regions as mean ± SEM (n = 6–7, four sections per animal, ∗∗p = 0.0082,
∗∗∗p = 0.0012 Mann–Whitney, two-tailed t-test). PV-WM, periventricular white matter; ST, striatum; OB, olfactory bulb; SVZ, subventricular zone; RMS, rostral
migratory stream; HF, hippocampus. (E) Representative images depicting vascular density in control and hypoxia + metastasis group. (F) Box and scatter plots with
minimum and maximum percentage vascular density (surface area µm3) mean ± SEM (n = 6–8), (∗∗p = 0.0090 unpaired, two-tailed t-test) (G) Stroke increases.
(Continued)
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FIGURE 1 | Continued
brain metastasis significantly more than hypoxia mediated angiogenesis. Bar graphs showing number of metastatic foci in stroke and hypoxic groups shown as
mean ± SEM (n = 6–8, four sections/animal, ap = 0.003, Mann–Whitney, two-tailed t-test). (H) Representative images from days 1 and 7 after stroke showing
localization of fluorescent microspheres in green and vasculature (PECAM) in red. (I) Box and scatter plots with minimum and maximum percentage volume of
fluorescent microspheres localized to the peri-infarct and contralateral regions at days 1 and 7 after stroke, mean ± SEM (n = 5–6, one-way ANOVA, Holm-Sidak for
multiple comparisons p = 0.46, ns, non-significant). (J) Schematics of the method of quantification of fluorescent microspheres volume localized around the
peri-infarct regions. (K,L) Representative immunohistochemical images and intensity of endogenous albumin extravasated from days 1 and 7 after stroke and
contralateral regions, mean ± SEM (n = 5, three regions/animal, ∗p = 0.0255, one-way ANOVA, Holm-Sidak for multiple comparisons).
(Termini et al., 2014). After stroke, neural stem cells in the
subventricular zone divide and differentiate into immature
neurons (termed neuroblasts), which migrate to brain tissue
adjacent to the stroke site and closely associate with angiogenic
blood vessels (Cook et al., 2017). We assessed the influence of
neuroblasts on metastatic melanoma localization to angiogenic
vessels within the regenerative neurovascular niche using genetic
labeling: a DCX-RFP mouse, in which red fluorescent protein is
expressed in neuroblasts and serves as an accurate reporter of
post-stroke neurogenesis (Cook et al., 2017). In these studies,
vessels are labeled with perfused lectin, and are rendered in
white for visualization in the black photomicrograph background
(Figures 2, 3).
Within 1 day after metastasis, 33± 5 metastatic foci seeded in
neuroblast-associated vessels in the peri-infarct of stroke animals
(p = 0.0354, n = 5–8), while there was no such metastatic
localization in the corresponding control cortex (p < 0.0001,
n = 5–8) (Figures 2A,B). On average, five metastatic foci localized
to vessels without neuroblasts in both control and stroke mice
groups. This suggests that blood vessels that support post-stroke
neurogenesis govern the preferential localization of metastatic
melanoma in the regenerative neurovascular niche.
Tissue Repair Augments Direct Cellular
Interactions Between Metastatic Cells
and Neurovascular Niche Components
As metastatic melanoma cells localize to the regenerative
neurovascular niche, they associate with distinct cellular niche
elements over time, such as angiogenic vessels, astrocytes,
and neuroblasts (Termini et al., 2014). These associations
between metastatic cells and niche components at day 7
after metastasis are shown on CLARITY-processed tissue after
stroke (Supplementary Video 1). To further determine cellular
relationships between melanoma cells and this niche, we
examined spatiotemporal interactions between the metastatic
cells and neurovascular components at 1, 3, 5, and 7 days after
metastasis in control and stroke cohorts. These time points reflect
early events in metastasis that determine metastatic cell survival
and extravasation.
Metastatic Melanoma Interact With
Neuroblasts Within the Regenerative
Neurovascular Niche
To examine direct interactions between metastatic cells and
neuroblasts (the two principal cells of the metastatic and
regenerative neurovascular niches) the number of neuroblasts-
melanoma contact surfaces were quantified over time in the
peri-infarct and corresponding control cortex at 1, 3, 5, and 7
days after metastasis. On average, 7.7± 1.2 contact surfaces from
neuroblasts interacted with the metastatic foci at day 1. Following
this, the number of interactions significantly reduced at day 3 to
1.1 ± 0.3 contact surfaces (p < 0.0001, n = 6–9). Further, at days
5 and 7, neuroblast contact surfaces steadily increased compared
to day 3 (4.7 ± 0.7, p = 0.0092, and 5.7 ± 1.2, ∗∗∗∗p = 0.0006,
respectively) in the stroke cohort. No interactions were found
in the corresponding control regions due to the absence of
neuroblasts in analyzed control regions (Figures 2C,D).
To determine the spatiotemporal distribution of neuroblasts
around melanoma cells, we analyzed neuroblast counts at 25 µm
distance intervals from the metastatic foci periphery (Figure 2E).
In the stroke cohort, 32 ± 10 neuroblasts were found at 1 day
after metastasis within a proximity of 25 µm. At day 3, 5 ± 1
neuroblasts surround metastatic foci in equal distributions at
increasing distances. At days 5 and 7, more neuroblasts migrate
closer to the metastatic foci, with 7 ± 2 neuroblasts surrounding
metastatic cells at day 5 and 17 ± 5 neuroblasts at day 7
(p = 0.0164, n = 5–8).
This data suggests that neuroblasts around the metastatic
foci associate with melanoma in two phases. At day 1, there
is a vascular phase: melanoma cells form a large number of
contacts with neuroblasts as they associate with neuroblast-
associated vasculature in the peri-infarct (Figures 2A,B). After
melanoma extravasation at day 3, melanoma separate from
the neuroblasts in the niche, followed by a tissue phase:
melanoma cell associations with neuroblasts increase until day 7
in the regenerative neurovascular niche (Figures 2C–E). These
distinct phases in neuroblast-metastasis interaction are unique
to the regenerative neurovascular niche. The corresponding
cortical regions in the metastasis-only (no stroke) group had no
metastatic foci associated with neuroblasts.
Tissue Repair After Stroke Enhances
Association Between Extravasated
Metastatic Cells and Surrounding
Reactive Astrocytes
Since reactive astrocytes play a crucial role in the neurovascular
niche and in brain metastasis (Klein et al., 2015), we assessed if
the regenerative neurovascular niche enhances reactive astrocyte
contact surfaces with the metastatic melanoma at 1, 3, 5, and
7 days after stroke. Extravasation of metastatic cells initiates
after 3 days in controls and within 1 day in stroke group.
A two-way ANOVA indicated that this accelerated time course
of extravasation was temporally dependent upon the presence of
regenerative neurovascular niche (p = 0.0008, variance 4.33%)
Frontiers in Neuroscience | www.frontiersin.org 9 April 2019 | Volume 13 | Article 297
fnins-13-00297 April 8, 2019 Time: 7:56 # 10
Prakash et al. Shared Cancer and Regenerative Niches in the Brain
FIGURE 2 | Repair augments direct cellular interactions between the metastatic cell and neurovascular niche. (A) Immunohistochemical analysis of metastatic
melanoma cells shown as GFP+ green, lectin-labeled vasculature in white and DCX+ neuroblasts in red. (B) Quantitative analysis of metastatic cell interaction with
vessels associated with or without neuroblasts shown as scatter plot with mean ± SEM (n = 5–8, four sections/animal, aap < 0.0001; bp = 0.0354, Kruskal–Wallis,
one-way ANOVA, Dunn’s for multiple comparisons). (C) Representative brain images of metastatic foci (GFP+) and neuroblasts (RFP+) over time (left). Control
groups did not associate with neuroblasts in the corresponding brain region. Schematic representation of distance bins (25 µm intervals) used to analyze neuroblast
distribution around metastatic foci. Bin closest to melanoma is shown in bright red and increasing distances showing in gradients of yellow and the farthest depicted
in gray (right). (D) Box and scatter plot showing number of neuroblast contact surfaces interacting with metastatic foci. Mean ± SEM (n = 6–9, ∗∗p = 0.0092,
∗∗∗∗p = 0.0006, aap < 0.0001; one-way ANOVA, Holm-Sidak post hoc test used for multiple comparisons). (E) Bubble plot depicting density and distribution of
neuroblasts around metastatic foci at 25 µm distances Mean ± SEM (n = 5–8, bp = 0.033, cp = 0.033, ∗p < 0.0164; one-way ANOVA, Holm-Sidak post hoc test
used for multiple comparisons). Bubble size represents number of neuroblasts and increasing distances are color coded as shown in schematic.
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FIGURE 3 | Repair enhances direct cellular interactions between the metastatic cell and astrocytes and increases neovascularization. (A) Representative images
showing metastatic melanoma interaction with reactive astrocytes during melanoma extravasation. (B) Quantitative analysis of % volume of metastatic cell
extravasated. Mean ± SEM [∗∗∗p = 0.0082, aap < 0.0001, two-way ANOVA, Holm-Sidak post hoc test used for multiple comparisons (n = 5–8)]. (C) Astrocyte
coverage at corresponding time points around each metastatic foci. Mean ± SEM [aap < 0.0001, ap = 0.0006, two-way ANOVA, Holm-Sidak post hoc test used for
multiple comparisons (n = 5–8)]. (D) Methodology of analysis of neovascularization and infection point analysis. (E) Changes in neovascularization response over
time mean ± SEM, (n = 5–8), (∗p = 0.0424, ∗∗p = 0.0349, ap = 0.0454, bp = 0.0015, cp = 0.0163, dp = 0.0474, ep = 0.0009, two-way ANOVA, Fisher LSD). (F) Bar
graphs showing temporal changes in inflection point ratios [∗p = 0.0032, ∗∗p = 0.0215; ∗∗∗p = 0.0012; aap < 0.0001; two-way ANOVA, Holm-Sidak post hoc test
used for multiple comparisons, (n = 5–8)].
(Figures 3A–C). Corresponding to the extravasation, astrocytic
processes begin interacting with extravasated melanoma early at
day 1 in the stroke group compared to day 3 in controls. Total
astrocytic contacts increase from 7 ± 2 at 3 days to 9 ± 2 at
5 days to 53 ± 10 at 7 days in control metastasis (p < 0.0001,
n = 5–8) while they increase from 20 ± 6 at day 3 to 26 ± 8
at day 5 to 70 ± 9 at day 7 in stroke+metastasis (p < 0.0001,
n = 5–8). Astrocyte contact surfaces linearly increase as metastatic
cells extravasate in both control and stroke (pooled slope: 7.706).
The presence of a regenerative neurovascular niche significantly
enhanced melanoma–astrocyte interactions independent of time
(two-way AVOVA, p = 0.0006) (Figure 3).
Regenerative Vasculature Is More
Susceptible to Metastatic Cell-Induced
Remodeling
The progression of brain metastasis is dependent upon the
hijacking or recruitment of adjacent vessels, a process known
as vascular cooption (Qian et al., 2016). To examine the
temporal increase in vessel recruitment with metastatic cells,
the distance between individual vessel segments and metastatic
cells were measured. After metastasis, direct vessel contact
with metastatic cells significantly increased from day 1 to
day 7 in both control and stroke cohorts with 0.75 ± 0.12
vessels in contact with metastatic melanoma at day 1 and
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1.8 ± 0.58 at day 7 in controls (p = 0.0424, n = 5–
8), and 0.93 ± 0.13 at day 1 and 1.93 ± 0.62 at day
7 in the stroke cohort (p = 0.0349, n = 5–8). While no
difference in direct vessel associations was observed between
cohorts, there was a significant increase in close proximity
vessels in the stroke groups compared to controls. Within a
periphery of 25 µm from the metastatic foci, vessel association
significantly increased from day 1 to day 7 in the stroke
groups compared to controls, with 1.65 ± 0.71 vessels at day
7 in control vs. 3.85 ± 0.43 at day 7 (p = 0.0015, n = 5–8)
in stroke (Figures 3D,E). A two-way ANOVA indicated that
the regenerative neurovascular niche significantly influenced
vascular associations independent of temporal effects (p = 0.0009,
variance 19.71%). This data suggests that vascular cooption is
essential to metastasis as early as 7 days and that this vascular
remodeling is significantly augmented in the regenerative
neurovascular niche.
When metastatic cells’ co-opt or route along vasculature,
they induce local irregularities in vessels (Bullitt et al., 2003,
2005). To assess these vessel irregularities, we utilized inflection
points, which measure the number of irregularities or changes
in direction within a curvature. We measured inflection points
on vessels associated with metastatic cells and normalized
over inflection points on vasculature not associated with
metastatic cells. Metastasis alone significantly increased inflection
points on associated vasculature at day 7 compared to day 1
(p = 0.0032, n = 5–7). However, after stroke, inflection point ratios
progressively increased at day 7 compared to day 1 (p < 0.0001,
n = 5–7) and were significantly higher compared to controls at
day 7 (p = 0.0012, n = 5–7) (Figure 3F). A two-way ANOVA
indicated that stroke significantly enhanced inflection points
independent of time. This data suggests that metastasis enhances
vascular irregularities as early as 7 days, and angiogenic vessels
within the neurovascular niche not only preferentially localize
melanoma cells but are then more susceptible to melanoma-
induced vascular remodeling.
Human Brain Metastatic Melanoma
Interact With Neuroblasts and Astrocytes
To identify the possible interactions of neuroblasts, astrocytes,
and metastatic cells in human brain tumors, we immunostained
representative human brain metastatic melanomas FFPE sections
obtained from elective surgeries with biomarkers for neuroblasts
(Tuc-4), astrocytes (GFAP) and melanoma (MART-1). Fifteen
distinct patient samples of brain metastasis were immunostained
and 4 of 15 tumors showed co-localization of metastatic with
neuroblasts (Figure 4). The presence of interactions between
human melanoma and surrounding neural cells implicated
in stroke repair suggests that elements of the regenerative
neurovascular niche play an important role in mediating
melanoma metastasis.
FIGURE 4 | Human brain metastatic melanoma interact with neuroblasts and astrocytes. (A) Representative image depicting characterization of antibodies on
human brain samples. Human hippocampus section showing staining for DCX, PSA-NCAM, GFAP, and Tuc-4. DCX positive neuroblasts colocalize with Tuc-4.
(B) Schematics showing human brain tumor margin immunostained for neuroblasts and astrocyte association. (C) Immunohistochemical representative images of
brain metastatic melanoma show novel interactions with neuroblasts excised from human patients (4/15 show close neuroblast–melanoma interactions).
(D) Representative images of brain metastatic melanoma from human patients show interactions with astrocytes.
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Isolation and Sequencing of Stroke
Responsive Metastatic Melanoma Cells
FACS sort was performed on YDFR-CB3GFP+ cells isolated
from both the peri-infarct region and the corresponding non-
stroke side. We developed an efficient method to purify and
enrich these metastatic cells using magnetic bead columns
that negatively selected human cells in the elute and retained
the mouse cells in columns bound to mouse cell specific
antibodies conjugated to beads. This elute enriched for human
cell population was gated for GFP and MCSP-PE channels
in FACS. For each sample, metastatic cells isolated from two
to three mice were pooled from the peri-infarct regions and
six to eight animals were pooled from the contralateral side
(n = 5–7) (Figure 5).
RNA sequencing performed on the metastatic melanoma cells
isolated in vivo from the stroke and the non-stroke side of
the brain resulted in 74–101.5 million reads per transcriptome.
The percent of uniquely mapped reads ranged from 79.37 to
86.23%. Samples with a minimum of 10 transcript counts were
used and batch correction was applied to remove unwanted
variation with k = 2 (Risso et al., 2014). Differentially expressed
genes between the metastatic cells isolated from the peri-infarct
region (stroke side) and the corresponding non-stroke brain
regions (contralateral hemisphere) were determined with the
bioconductor edgeR package (Robinson et al., 2010).
Molecular Signaling Systems in
Regeneration-Potentiated Brain
Metastasis
To determine the unique gene expression changes that occur
within metastatic melanoma in the presence of regenerative
neurovascular signaling, we sequenced total RNA extracted from
FACS-isolated, regeneration-potentiated metastatic melanoma
cells in vivo from the peri-infarct cortex vs. metastatic melanoma
cells not localized to the neurovascular niche after stroke. Cell-
specific RNA-sequencing identified 4,083 differentially expressed
genes between metastatic melanoma cells (stroke vs. non-stroke
p ≤ 0.05). Filtering this significantly regulated gene list for log2
(fold change) ≥ ±0.5 resulted in 2,264 genes in regeneration-
potentiated metastatic melanoma cells vs. brain metastases not
in the stroke site. Because this transcriptome comes specifically
from a subtraction of metastatic melanoma gene expression
FIGURE 5 | (A) Schematic representation of tissue processing and FACS sort methodology performed. (B) Gating areas used during FACS and the GFP and
MCSP-PE double positive cells were isolated for RNA sequencing. MCSP, melanoma-associated chondroitin sulfate proteoglycan.
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in non-stroke vs. the potentiated state of stroke, this is a
unique transcriptome of melanoma specific to the regenerative
neurovascular niche, termed the Stroke-MET transcriptome:
1,118 genes are upregulated and 1,146 are downregulated in
metastatic melanoma within the regenerative neurovascular
niche compared to melanoma brain metastases outside of this
niche. The organization of differentially regulated genes in the
Stroke-MET transcriptome was studied by association into top-
scoring canonical molecular pathways (Figure 6). Canonical
pathways strongly activated in the Stroke-MET transcriptome
include axon guidance, ephrin receptor signaling, phagosome
formation, and thrombin signaling. A volcano plot of the
significant differentially expressed genes identifies those genes
with the highest fold change and most significant expression
in the Stroke-MET transcriptome (Figure 6). Twenty-two of
these genes are reported to have extensive roles in determining
metastasis as tabulated in Table 1.
We utilized Gene Set Enrichment Analysis (GSEA) to refine
this dataset and identify genes with common biological functions
based on curated datasets (Subramanian et al., 2005). Using
directional p-values for differential expression in the Stroke-
MET transcriptome, we identified 50 hallmark gene sets, of
which 21 were upregulated and 29 were downregulated. At
an FDR < 0.05, 7 upregulated and 15 downregulated gene
sets were significantly enriched in Stroke-MET (Figures 6D,E).
The gene-set enrichment analysis indicated an enriched up-
regulation of PI3K-mTOR pathway (Sarris et al., 2012) and
downregulation of p53 pathway (Oren, 2003) often associated
with tumor progression in cancer. These analyses of gene classes
and identification of specific genes uniquely expressed in stroke-
melanoma metastasis vs. “general” brain metastasis identifies
many that are associated with neuronal pathfinding, neuronal
tropic and trophic interactions and neuronal cell motility,
supporting a role of the metastatic cell in an analogous position
in the regenerative neurovascular niche to the normal principle
cell in this niche, the neuroblast.
Mimicking Stroke-Like Conditions With
Oxygen-Glucose Deprivation (OGD)
Facilitates Brain Metastasis
To model the influence of stroke on melanoma metastasis in vitro,
we assessed the (a) metastatic properties and (b) molecular
profile of melanoma cells in stroke-like conditions using a well-
established in vitro model: OGD (Hillion et al., 2005). Metastatic
cells were treated with conditioned media harvested from human
brain endothelial cells (h-EC) or human astrocytes (h-Astro)
subjected to either OGD or control conditions of normal oxygen
and glucose levels.
Oxygen Glucose Deprivation (OGD)
Enhances Chemoattraction of Melanoma
Cells by Brain Cells
Oxygen Glucose Deprivation (OGD) Enhances
Migration of Melanoma Cells
Since cell migration is an essential component of the metastatic
cascade (van Zijl et al., 2011), we examined the directed migratory
capacity of brain metastatic melanoma in response to cues from
h-EC and h-Astro after OGD and control conditions. Melanoma
cells were added upon a collagen-coated Transwell insert and
allowed to migrate toward h-EC/h-Astro subjected to OGD or
control conditions. While melanoma cells displayed significantly
increased migration toward OGD-exposed h-EC compared to
control conditions (p < 0.05), OGD-conditioned media from
h-Astro did not significantly alter migration (Figure 7C). OGD
exposed h-EC also displayed enhanced adhesion of metastatic
melanoma cells, which was reduced by blocking VCAM-1
(Figure 8). Thus, metastatic characteristics in melanoma cells can
be enhanced by recapitulating stroke-like conditions in vitro, and
this in vitro results suggest that endothelial cells are key mediators
of regeneration-potentiated metastasis.
OGD Alters Cytokine/Chemokine Responses in
Astrocytes and Endothelial Cells in vitro
We next examined the secreted factors from OGD-exposed
endothelial cells and astrocytes to determine signaling cues that
play a role in the in vitro migration findings, and isolate the
influence of individual cell types on metastatic cells. To identify
these candidate factors, secreted and extracellular molecules from
h-EC (OGD vs. control) and h-Astro (OGD vs. control) were
measured using a cytokine array. Thirty-two cytokines (fold
change < −1.2 or > 1.2) were differentially secreted from OGD
vs. control h-EC and 19 were differentially secreted from OGD
vs. control h-Astro (Figures 7D,E). To identify gene ontologies in
these in vitro stroke-endothelial and stroke-astrocyte secretomes,
enrichment depletion (simultaneous analysis of enriched: over-
represented DE genes and depleted: under-represented genes
between two states) (Rivals et al., 2007) was performed for both
cellular processes and molecular functions. Both endothelial and
astrocyte-derived OGD secretomes were enriched for cytokine
and growth factor receptor activity while endothelial-derived
secretomes displayed additional enrichment of chemokines,
Ras-GTP, and protein kinase activity, further supporting the
central role of endothelial cell in contributing to this pro-
metastatic niche.
OGD Reduces Viability of Human Brain Endothelial
Cells and Astrocytes
The viability of neurovascular niche cells was assessed under
OGD conditions. Human brain h-EC and h-Astro were subjected
to OGD or control (normoxic) conditions for 4 h followed
by 4, 20, and 44 h of normoxia recapitulating reperfusion.
Cell viability was then measured by XTT assay. The results
showed that h-Astro were more sensitive to OGD than
h-EC (Figures 8A,B). While the viability of the h-Astro was
significantly reduced after 4 h of OGD conditions (t = 0, p< 0.05),
a significant reduction in h-EC viability only occurred after
44 h (p < 0.05). When the normoxic phase was prolonged,
“stroked” astrocytes showed a gradual recovery over time (20
and 44 h after start of the reperfusion phase). These findings
mimic spontaneous recovery of neurovascular components
observed after stroke.
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FIGURE 6 | Molecular signaling systems in regeneration-potentiated brain metastasis. (A) Schematic representation of flow of transcription profiling and regenerative
neurovascular niche components interacting with metastatic cells. Significant and differentially expressed genes between regeneration-potentiated and contralateral
metastatic cells as determined by log2 fold change > 0.5 and p < 0.05 (Stroke-MET). (B) Top differentially regulated canonical pathways with largest negative logP
shown in metastatic melanoma cells from the regenerative neurovascular niche compared to contralateral tissue. The dashed line represents the ratio of the number
of molecules in the dataset over the number of molecules in the pathway. (C) Volcano plot showing p-values correlated with log2 fold change in metastatic cells
isolated from regenerative neurovascular niche vs. contralateral side. Genes systematically identified from top pathways from (B), are marked in blue. (D,E) GSEA of
hallmark genes up and downregulated in the Stroke-MET transcriptome. Estimated probability of FDR < 25% represent 3/4 chances of a gene set being valid.
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TABLE 1 | Functionally relevant gene identified from Stroke-MET transcriptome.
Gene Log2 FC Pathways regulated (Figure 6) Reported function(s) (database used: pubmed) References
NTNG1 −1.922 Axon guidance Axonal growth protein also expressed in stroma of
human PDAC.
Rollins, 2016
High methylation status associated with poor outcomes
in colorectal cancer.
Sho et al., 2017
Promote axon outgrowth. Lin et al., 2003
Unreported in brain metastasis
HHIP −1.775 Axon guidance Regulates endothelial cell proliferation/migration
through Hedgehog pathway inhibition
Yan et al., 2014
Gli-Hedgehog signaling enhances melanoma
proliferation
Stecca et al., 2007
Methylated in pancreatic cancer Martin et al., 2005
Decreases VEGF-mediated tumor angiogenesis Agrawal et al., 2017
Down-regulated during tumor angiogenesis in human
tumors
Olsen et al., 2004
IGF1 1.458 Axon guidance, fibrosis Enhances survival of breast cancer brain metastasis. Palmieri, 2012
IGF promotes EMT and stemness via NANOG and
STAT3 signaling (melanoma brain metastasis)
DeVita et al., 2012; Yao C.
et al., 2016
IGF-1 supports tumor proliferation in melanoma
metastasis.
Capoluongo, 2011
GAB1 1.489 Axon guidance, neuropathic pain,
phagosome formation, Tec kinase,
leukocytes, role of macrophages,
fibroblasts, and endothelial cells,
Rho family, thrombin signaling,
aldosterone signaling
Mediates tumor angiogenesis in melanoma through Akt
and ERK1/2 pathways.
Zhao et al., 2011
GAB1 upregulation promotes tumor cell invasion,
migration via CXCR4 and tumor growth.
Vasyutina et al., 2005;
Seiden-Long et al., 2008; Sang
et al., 2015
GAB1 enhances vascular sprouting via VEGF-induced
eNOS activation.
Lu et al., 2011
GNA14 1.935 Axon guidance, ephrin receptor
signaling, Tec kinase, Rho family,
thrombin signaling
Inhibits cell differentiation and enhances tumorigenicity
after TNFa stimulation
Oshima et al., 2014
Activates STAT3 signaling, NF-kB and Ras-dependent
pathways
Liu and Wong, 2005; Kwan
et al., 2012; Lee et al., 2012
CXCR4 2.175 Axon guidance, ephrin receptor
signaling, leukocytes
Highly expressed in brain metastases across cancer
types (breast, lung, kidney, colon, ovary, prostate, and
thyroid).
Salmaggi et al., 2009
Activation of CXCR4-CXCL12 axis enhance tumor cell
migration.
Chung et al., 2017
CXCR4 disrupts vascular permeability through
PI3K-AKT and FAK pathway.
Weidle et al., 2016
CXCR4 induces growth and metastasis of cancers
including melanoma regardless of organ specificity
Kim et al., 2006; Burnett et al.,
2015
RAC2 2.711 Axon guidance, ephrin receptor
signaling, leukocytes
Rac2 promotes melanoma metastasis and tumor
angiogenesis.
De et al., 2009; Joshi et al.,
2014
Rac2 activates SDF-1/CXCR4 system Shen et al., 2012
GRIA4 −1.966 Neuropathic pain GLUR4 knockdown enhances cell viability and
proliferation, while stimulating cancer cell migration
(through upregulation of MMP2 and integrins)
Luksch et al., 2011
Found to be hypermethylated in cancers (follicular
lymphoma/oropharyngeal squamous cell carcinoma)
compared to benign lesions
Kostareli et al., 2013
GluR4 signaling activates MAPK and K-ras signaling
(decreasing threshold of K-ras induced oncogenic
signaling) in pancreatic cancer lesions
Herner et al., 2011
Downregulated in glioma cells. Savaskan et al., 2011
RND2 −1.746 Phagosome formation, Rho family,
thrombin signaling
Downregulated in melanoma compared to melanocytes Wen et al., 2017
Enhances melanoma susceptibility to low dose cisplatin
treatment through PARP cleavage and activation.
Ho et al., 2012
Aza treatment sensitizes melanoma cells to
therapeutics by upregulating RND2.
Halaban et al., 2009
(Continued)
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TABLE 1 | Continued
Gene Log2 FC Pathways regulated (Figure 6) Reported function(s) (database used: pubmed) References
RHOV 2.88 Phagosome formation, Tec kinase,
Rho family, thrombin signaling
Overexpressed in lung cancer and NSCLC lines Wang et al., 2017
Signal transducer for PAK6, protein kinase implicated in
prostate cancer chemoresistance
Shepelev and Korobko, 2012
JAK3 1.468 Tec kinase Activates STAT5A Sharfman, 2012
Activates PD-L1 antitumor suppression in melanoma cells Jiang et al., 2013
Promotes squamous cell carcinoma migration and
proliferation
Zhang et al., 2017
Expressed at higher levels in brain metastases of melanoma
compared to primary melanoma
Kesari et al., 2015
FRK 1.627 Tec kinase Causes PTEN deregulation and is overexpressed in
melanoma
Bosserhoff, 2017
Enhances tumor progression in cell-type specific manner Zhao et al., 2011
STAT5A 2.211 Tec kinase Enhances cell viability, proliferation, and growth. Mirmohammadsadegh et al.,
2006; Hassel et al., 2008; Liao
et al., 2010
STAT5a inhibition enhances cisplatin susceptibility. Zhang, 2012
Activated in melanoma cells by EGFR and JAK1 and SRC Rochman et al., 2010
Active STAT5a signaling induces EMT and CSC markers and
promotes metastasis in prostate cancer
Schmidt et al., 2014
PIP5KL1 −1.805 Aldosterone signaling, Rho family PIP5KL1 upregulation suppresses tumor cell proliferation,
migration, and growth.
Shi et al., 2010a,b
Overexpression of PIP5KL1 markedly inhibited (P < 0.05)
serum-induced phosphorylation of AKT1
Shi et al., 2010b
PIP5KL1 transduction induces apoptotic changes in 293T
cells
Wang et al., 2006
GATA3 −1.525 Thrombin signaling GATA3 suppression promotes EMT, metastasis and
suppresses cell differentiation and alters the tumor
microenvironment by inducing angiogenesis in breast cancer.
Chou et al., 2010, 2013
Genomic analyses reveal a high frequency target mutation of
GATA3 in breast cancer, melanomas, clear cell sarcoma and
poor prognosis.
Miettinen et al., 2014; Takaku
et al., 2015
GATA3 is a negative regulator of tumor invasion and growth. Takaku et al., 2015
Ectopic GATA3 ablates canonical TGF-β-Smad
signaling axis.
Sun et al., 2013
DKK1 −4.852 Role of macrophages, fibroblasts,
and endothelial cells
DKK1 is hypermethylated in several cancer types. Mazon et al., 2016
3 DKK1 protein secretion abrogated in melanoma however
reported in breast, prostate and lung cancer lines.
Kuphal et al., 2006; Forget et al.,
2007
4 DKK1 suppresses melanoma cell invasion. Chen et al., 2009
5 Temsirolimus (mTOR inhibitor) potentiates temozolomide
(second line treatment for brain cancers) in metastatic
melanoma by DKK1 pathway.
Niessner et al., 2017
FRZB −1.783 Role of macrophages, fibroblasts,
and endothelial cells
Hypermethylated in melanoma and methylation promotes
melanoma migration and invasion.
Ekström et al., 2011; Micevic
et al., 2017
FRZB reverses EMT in pancreatic cancer. Zi et al., 2005
IL32 −1.746 Role of macrophages, fibroblasts,
and endothelial cells
IL-32α administration prevents human melanoma proliferation
through p21, p53 and TRAILR1.
Nicholl et al., 2016
STAT1 and IL-32 signaling mediates immunoresponse upon
TLR2/6 agonists and IFN-gamma treatment in melanoma.
Mauldin et al., 2014
IRAK2 1.696 Role of macrophages, fibroblasts,
and endothelial cells
IRAK2 and LAMP1 are negatively regulated by miR-373. Farooqi et al., 2015
Novel role of IRAK2, RAF6, and Ras in p38 MAPK activation. McDermott and O’Neill, 2002
Highly expressed in malignant melanomas. Li et al., 2009
C5 1.528 Role of macrophages, fibroblasts,
and endothelial cells
C5a promotes the development and growth of melanoma
(targeted melanoma therapy using complement-inhibitory
drugs).
Nabizadeh et al., 2013
C5a inhibition blocks tumor progression and angiogenesis. Corrales et al., 2012; Nitta et al.,
2013
(Continued)
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TABLE 1 | Continued
Gene Log2 FC Pathways regulated (Figure 6) Reported function(s) (database used: pubmed) References
CLDN1 −2.537 Leukocytes Claudin-1 acts as a metastasis suppressor, and loss of
claudin-1 is positively correlated with poor outcomes in lung
adenocarcinoma.
Chao et al., 2009
Claudin-1 prevents brain metastasis of melanoma. Izraely et al., 2015
Decreased expression in vessels associated with melanocytic
neoplasms.
Cohn et al., 2005; Leotlela et al.,
2007
CTNNA2 −1.483 Leukocytes Deleted in MEL10 and predicted to be a tumor suppressor. Fanjul-Fernández et al., 2013;
Ding et al., 2014
FIGURE 7 | OGD alters chemokine/cytokine responses in the neurovascular niche and enhances migration of brain metastatic cells. (A) Schematics showing the
interaction of human astrocytes (h-Astro) and human endothelial cells (h-EC) with metastatic melanoma cells. (B) Schematics of method of oxygen glucose
deprivation (OGD) conditioned media exposed to metastatic melanoma cells. (C) Migratory response of metastatic melanoma cells exposed to OGD conditioned
media from cells are shown as mean ± SD, ∗P < 0.05. (D,E) Heatmap of relative expression of secreted proteins profiled from the medium of h-Astro (E) and h-EC
(D). Functionally grouped enriched pathways are shown in one color. Enrichment/depletion tests performed with ClueGO application on cytoscape, κ score ≥ 0.4.
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FIGURE 8 | Oxygen-glucose deprivation (OGD) affects viability of human-endothelial cells (h-EC), astrocytes (h-Astro) and adhesion of metastatic melanoma cells.
(A,B) Percentage viability of h-EC (A) and h-Astro (B) subjected to OGD for 4 h followed by a 4, 20, and 44 h reperfusion phase. Cell viability as measured by XTT
assay. The bars represent the average % viability of OGD exposed cells, normalized to control cells subjected to normal oxygen and glucose levels, mean ± SD,
∗p < 0.05. The different time points indicate the hours in reperfusion after OGD/control conditions. (C) h-EC were subjected to OGD for 4 h followed by a 20 h
reperfusion phase. m-Cherry expressing macro- and micro-metastatic melanoma cells were seeded on top of the h-EC monolayer and incubated for 30 min, to
allow adhesion to occur. The fluorescence signal of labeled cells was measured before and after removal of non-adherent cells. The bars represent the % adherent
cells in the wells. The graph represents an average of three independent experiments + SD. ∗P < 0.05. (D) m-Cherry expressing metastatic melanoma cells were
seeded on top of the OGD or control h-EC monolayers and incubated for 30 min with 5 µg/mL VCAM-1 blocking Ab, an isotype control (mIgG1), or without IgG. The
fluorescence signal of labeled cells was measured before and after removal of non-adherent cells. The bars represent % adherent melanoma cells seeded with
anti-VCAM-1 blocking Ab or isotype control normalized to % adherent melanoma cells seeded without Ab. The graph represents an average of two independent
experiments + SD. ∗p < 0.05.
OGD Enhances the Adhesive Capacity of h-EC to
Metastatic Melanoma Cells
A crucial initial step in melanoma cell transmigration through
the brain vasculature is the adhesion of cancer cells to the
endothelium. To investigate whether OGD enhances the ability
of h-EC to bind melanoma cells, we compared the adhesion of
brain-metastasizing melanoma cells to OGD and control h-EC.
The brain-metastasizing melanoma cells showed significantly
greater adherence to OGD exposed h-EC than to control
(Figures 8C,D). This result suggests that stroke-like conditions
recapitulated by OGD facilitates the formation of brain metastasis
by making h-EC more amenable to tumor cell adhesion. The
expression of the endothelial cell adhesion molecules ICAM-1
and VCAM-1 was tested in control and OGD exposed h-EC.
Flow cytometry analysis demonstrated a slight up-regulation
in the expression of both molecules following OGD (data not
shown). To further demonstrate the increased adherence of h-EC
to metastatic melanoma cells, YDFR-CB3m-Cherry cells were
co-cultured with h-EC and the above experiment was similarly
performed in the presence of a VCAM-1 blocking antibody.
Inhibiting VCAM-1 significantly decreased OGD (and not
control) h-EC adherence to YDFR-CB3m-Cherry suggesting its
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importance in brain metastasis in the regenerative neurovascular
niche (Figure 8D).
Transcription Landscapes From
Regenerative Niche and Melanoma Brain
Metastasis: in vivo and in vitro Overlaps
To delineate the influence of specific niche cells
(endothelial/astrocytes) upon the metastatic transcriptome
in vitro, we sequenced the total RNA from metastatic melanoma
in conditioned media harvested from h-EC or h-Astro subjected
to OGD or controls. The differentially expressed (DE) genes
from OGDEC-MET/OGDAstro-MET were compared with the
transcriptional in vivo profile of regeneration-potentiated
melanoma (Stroke-MET) to determine overlap between the
in vivo and in vitro studies.
We performed a rank–rank hypergeometric overlap (RRHO)
that compares the ranked order and the log10-transformed
t-test p-value of in vitro differentially expressed genes to in vivo
differentially expressed genes in this melanoma cell line, and
in stroke conditions. The heat maps show that top ranked
genes in OGDEC-MET overlapped with those of Stroke-MET
to a greater extent than OGDAstro-MET (Figures 9C,D). An
assessment of overlapping canonical signaling systems reveals
that the top highly up/down-regulated pathways all play
important potential or predicted roles in governing melanoma
metastasis: PPAR/RXRα, angiopoietin signaling, mTOR,
Semaphorin signaling between the Stroke-MET and OGDEC-
MET transcriptome, and ephrin receptor signaling in both
Stroke-MET and OGDAstro-MET transcriptomes (Figures 9A,B).
This analysis indicates that the in vitro melanoma profile, when
exposed to stroke-conditioned endothelial cells, significantly
overlaps with the in vivo melanoma gene expression profile
in the stroke regenerative neurovascular niche, but not that of
melanoma exposed to stroke-conditioned astrocytes.
To move forward on this similarity, a comparison of genes
similarly up and down regulated genes in in vivo regeneration-
potentiated melanoma transcriptome (Stroke-MET) and in vitro
OGDEC-MET transcriptome showed 343 overlapping significant
genes (p < 0.05) of which 49 were upregulated and 141
were downregulated. Stroke-MET transcriptome compared to
OGDAstro-MET transcriptome showed 45 significant genes,
of which 17 were upregulated and 13 were downregulated
(Figures 9E–J). This gene list is small and provides a tractable set
of genes for mechanistic study in their effect on tumor metastasis
and stroke neurovascular responses.
We previously showed that brain metastasizing melanoma
express a unique set of genes distinct from that found in
cutaneous melanoma (Izraely et al., 2012). Some of these genes
are known as metastasis-mediating genes. Our objective was to
examine whether the expression of this set of genes is altered
in melanoma cells subjected to in vitro post-stroke reperfusion
conditions, i.e., to supernatants of “stroked” astrocytes. We
incubated “stroked” and control astrocytes in starvation medium
for 20 h to allow secretion of post-stroke soluble factors into the
medium, collected these supernatants, and added them into brain
metastatic melanoma cultures. We observed an upregulation in
the expression of ANGPTL4, COX2, and CYR61, and a slight
downregulation in MMP1 expression. These results suggest that
stroked astrocytes secrete factors that may induce the metastatic
potential of melanoma cells (Figure 10).
To identify putative molecular interactions that facilitate
metastasis in stroke-like conditions, we profiled membrane
and secreted proteins between endothelial cells/astrocytes, and
metastatic melanoma in the regenerative neurovascular niche. An
interaction map was generated of putative interactions between
regeneration-potentiated melanoma cells and the two cells in the
regenerative neurovascular niche that were determined to have a
demonstrated in vitro effect on melanoma metastasis–astrocytes
and endothelial cells. This approach used significantly regulated
genes in in vivo regeneration potentiated melanoma that were
membrane-bound or secreted, and had signaling partners on
another cell type: astrocyte–melanoma and endothelial cell-
melanoma exposed to OGD in vitro. A greater number of
molecular interactions between endothelial cells and metastatic
melanoma were identified compared to astrocytes. Interestingly
PROM1 a surface marker of tumor initiating cancer cells (Raso
et al., 2011) was found in both interactomes. IL-6 and CCL2 had
the most number of signaling partners in both the interactomes.
These putative molecular interactions can be used to explore
the functional significance of target molecules, and characterize
the dynamic interactions that occur between metastatic cells
and the regenerative neurovascular niche to drive regeneration-
potentiated metastasis (Figure 11).
Network Analysis of Prognostic Gene
Expression Profiles Identify Key Central
Mediators
To gain insights into system-level properties of biologically
important genes, the significantly regulated genes in
regeneration-potentiated melanoma (Stroke-MET) were
grouped into networks and assigned focus scores based on
p-values. Using network analysis allows us to identify genes of
a high functional and biological significance in the metastatic
cells within the regenerative niche. Focus scores indicate the
likelihood of genes within a network being found together,
taking into account the size of the network based on relevance
to disease or function (Long et al., 2004). The genes with
specific connectivity belonging to disease classes from the
Stroke-MET transcriptome with highest focus scores were
used for centrality analysis (Cytoscape, CytoNCA). Centrality
analysis identifies genes that are highly interconnected and
influence a large number of other genes within a network.
We identified these central genes from three classes of gene
networks with coordinated functions and diseases including
neurological disease and injury, development, and cancer
(Tang et al., 2015). We determined the degree and betweenness
centrality of the central genes, which are designated by large
node size in the networks (Figures 12A–C). A gene’s degree
and betweenness centrality represents its interconnectedness
to other genes in the network, and its influence over adjacent
genes, respectively (Ozgur et al., 2008). Centrality values are
provided in Table 2. From these networks we identified APP,
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FIGURE 9 | Overlapping transcription landscapes from regenerative NV niche after stroke and melanoma brain metastasis. (A,B) Common canonical signaling
pathways between the in vivo Stroke-MET and in vitro OGD-ECMET/OGD-AstroMET transcriptome. (C,D) Rank–rank hypergeometric overlap (RRHO) analysis of
common genes expression spread between Stroke-MET and OGD-ECMET/OGD-AstroMET transcriptome. RRHO analysis of common genes expression spread
(Continued)
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FIGURE 9 | Continued
between Stroke-MET and OGD-AstroMET datasets. Red and blue pixels on the heatmap depict a high and low number of overlapping genes, respectively.
Stroke-MET and OGDEC-MET display stronger hypergeometric overlap those with OGDAstro-MET transcriptome. (E,F) Overlapping up and downregulated genes
between in vivo Stroke-MET and in vitro OGD-ECMET/OGD-AstroMET transcriptome are depicted in the Venn diagram. (G–J) Heatmap of log2 FC of overlapping
genes between Stroke-MET and OGD-ECMET/OGD-AstroMET transcriptome. The up and down regulated overlapping genes are shown in red and blue a change in
gradients of these color correspond to the level of log2 FC as shown on the scale bars. Genes classified based on the cellular location and the color coded as shown
in the key at the bottom of the heatmaps : Blue: extracellular, green: plasma membrane, orange: cytoplasm, violet: nucleus, and black: other.
FIGURE 10 | Gene expression changes in OGD exposed metastatic melanoma cells. (A) The effect of OGD exposed astrocyte secreted factors on melanoma gene
expression. Astrocytes were subjected to OGD or control conditions for 4 h followed by a 20 h reperfusion phase. Metastatic melanoma cells were treated for 24 h
with the OGD or control conditioned media collected from the reperfusion phase. Total RNA was extracted and gene expression was determined by RT-qPCR.
mRNA expression levels were normalized to the expression of RS9. Bars represent gene expression in cells treated with conditioned medium of “stroked” astrocytes
normalized to gene expression in cells treated with control astrocyte conditioned medium mean ± SD of three independent experiments, ∗p < 0.05, ∗∗p < 0.01.
(B) Primer sequences used for the qPCR analysis shown in (A,B).
RPTOR, and TAZ (neurological injury network), extracellular
matrix signatures such as collagen I, IV and FAK (cancer
network) as central genes that are predicted master regulators
specific to brain metastasis and potential targets for further
experimental analysis.
To further identify the unique molecular profile of metastatic
melanoma cells within the regenerative neurovascular niche
after stroke, we compared the differentially expressed genes of
these cells in this niche to those in metastatic melanoma cells
outside of this niche, in liver metastasis. To identify biological
variation without interference from different isoform abundance,
we determined differences at the gene-level that are identifiable
based on a RefSeq model (Soneson et al., 2015). FPKM values
above 4 were used as a cut off to identify unique molecules
in brain metastasis and liver metastasis (Figures 13A,B). While
gene-level overlap tests for overall changes in transcriptional
output of a gene, individual transcripts may have different
mechanisms or effects on compared conditions. To further to
detect these changes in transcript isoforms, we used the Ensembl
model at the transcript-level (Conesa et al., 2016). A core
comparison analysis showed that top canonical pathways are
composed of chemokines and cytokines in the brain compared
to the liver metastasis (Figure 13C). Interestingly, genes and
pathways involved in axon guidance and neuropathic pain are
significantly enriched in the brain metastasis compared to the
liver. GSEA analysis of hallmark gene sets show 4 upregulated
and 15 downregulated pathways significantly enriched in the
differentially expressed transcriptome of Stroke-MET vs. liver-
metastasis (Figures 13D,E). Brain metastasis to the regenerative
neurovascular niche exhibits a unique signaling signature
involving repair pathways not observed in distant metastasis.
DISCUSSION
The dynamic cross-talk between cancer cells and neural niche
elements provides insight into the influence of the tumor
microenvironment on metastasis. Neuronal precursor cells,
astrocytes, and endothelial cells have all been found to play
a crucial role in creating a permissive niche that drives
metastatic success (Psaila and Lyden, 2009; Venkatesh et al.,
2015). In both neural injury and brain metastasis, the local
microenvironment undergoes analogous cellular and molecular
changes that influence cell proliferation, differentiation, and
survival (Chen B. et al., 2009; Termini et al., 2014). Both
tumor progression and regenerative tissue reorganization require
angiogenic vasculature, co-localization of a progenitor or tumor
cell, and dynamic cell–cell signaling (Ohab et al., 2006;
Prakash and Carmichael, 2015; Carmichael, 2016). In this
study, we provide compelling evidence that cues emanating
from the regenerative neurovascular niche facilitate brain
melanoma metastasis.
The present data indicate that cellular and molecular
features of the regenerative neurovascular niche induce the
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FIGURE 11 | Astrocyte–metastatic cell and endothelial cell–metastatic cell interactome. Extracellular and plasma membrane bound proteins were chosen to
determine putative gene interactions between metastatic melanoma cell with two cell types in the regenerative neurovascular niche–astrocyte/endothelial cells.
Astrocyte–metastatic cell interactome display differentially expressed proteins in blue shows OGD exposed astrocyte secretome (blue panel) and their interactions
with Genes in the metastatic melanoma cells from the Stroke-MET transcriptome colored in green (green panel). Endothelial cell–metastatic cell interactome
differentially expressed proteins in red shows OGD exposed astrocyte secretome (red panel) and their interactions with genes in the metastatic melanoma cells from
the Stroke-MET transcriptome colored in green (green panel). Yellow panels depicts molecules in the extracellular space. Molecules in yellow: secretome, red: OGD
exposed endothelial cells, blue: OGD exposed astrocytes, green: stroke responsive melanoma Stroke-MET.
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FIGURE 12 | Gene network analysis of highly repetitive classes of coordinated diseases and functions from the Stroke-MET transcriptome. Network of gene
interactions representing genes associated with “cancer” (A), “Neurological disease and injury” (B), “Development” (C). Red: upregulated genes, blue:
downregulated genes, and larger nodes: central and highly connected genes. Nodes shown in gradients of red and blue are up- and down-regulated, respectively.
Centrality values are provided in the Table 2. Central genes with higher connectivity with neighboring genes are shown as larger nodes in each category.
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TABLE 2 | Centrality values of differentially regulated genes.
Disease Network Centralities
Degree Eigenvector Betweenness
Cancer
XP01 17 0.08596991 3300.861
SMAD3 16 0.3436861 3565.8477
snRNP 15 0.012245474 2225.245
collagen 15 0.32417372 1237.3102
Collagen type I 12 0.31365713 1503.7742
Focal adhesion kinase 11 0.26898885 1088.7654
COL1A1 11 0.3225594 504.3585
Collagen type IV 10 0.24174887 657.4651
HSP90AB1 9 0.12958206 1337.7277
p85 (pik3r) 9 0.16082734 1101.0994
Neur. Disease and Injury
APP 56 0.6285145 14092.723
TRAF6 17 0.26952243 2496.349
Jnk 14 0.19043593 2337.5176
TAZ 11 0.11805606 2943.962
TCTN2 10 0.03490787 1265.8921
RPTOR 9 0.18103331 1985.5358
Development
TNF 48 0.5610349 11893.423
NFkB (complex) 23 0.28850913 4632.912
Akt 21 0.30290568 5351.877
CALM1 11 0.12641135 1627.4298
Sfk 9 0.21849017 400.375
CSK 9 0.16786034 1086.8019
CCT7 9 0.02809526 1204.9857
preferential localization of melanoma to the peri-infarct over
other brain regions independent of changes in cerebral blood
flow, blood–brain barrier breakdown, and vascular permeability
normally found after stroke. Metastatic melanoma localized
specifically to regions on angiogenic blood vessels closely
associated with neuroblasts. However, angiogenic vessels alone
were not sufficient to produce the significant amount of
brain metastasis seen in stroke. This differential localization
of metastatic melanoma to blood vessels associated with
migratory neuroblasts identifies a central cellular complex in
the regenerative neurovascular niche that enhances melanoma
metastasis. After the initial localization of metastatic cells to
neuroblast-associated angiogenic vessels, there is a progressive
increase in spatiotemporal associations between neuroblasts
and melanoma. Interestingly, we confirmed that neuroblasts
interact with metastatic melanoma cells in human brain
melanoma metastases. Taken together, these findings point
to a novel, potentially crucial role of neuroblasts in brain
metastasis raising new questions as to how neuroblast–
melanoma interactions facilitate brain metastasis on a cellular
and molecular level.
Brain endothelial cells and astrocytes are key supportive
elements involved in repair processes within the regenerative
neurovascular niche after stroke that are vital for efficient
metastasis (Ohab et al., 2006; Langley and Fidler, 2013). The
regenerative neurovascular niche significantly enhances
melanoma-vasculature interactions in vivo, providing a
compelling role for endothelial cells in mediating this
regeneration-potentiated metastasis. Metastatic melanoma
cells within this specialized niche also modify phenotypic
structure of the surrounding vasculature. Interactions
with astrocytes occur after extravasation but the course of
astrocytic interactions is unaltered in the presence of the
regenerative neurovascular niche. Thus cross-talk between
melanoma and the specialized vasculature that is associated
with neuroblasts governs brain metastasis in the regenerative
neurovascular niche.
To further tease out the influence of stroke repair on the
metastatic transcriptome, we isolated regeneration-potentiated
melanoma cells and compared these to brain metastatic
melanoma cells outside of the regenerative neurovascular niche
using RNAseq. We identify 22 differentially regulated genes in
regeneration-potentiated metastatic cells that activate molecular
programs strongly implicated within metastasis, including
established oncogenes such as JAK3, STAT5A, RHOV, and RAC2.
To isolate molecular interactions between metastatic cells
and individual cells in the regenerative neurovascular niche, we
mimicked stroke-like conditions in vitro using OGD. Metastatic
migration was significantly enhanced in response to OGD-
exposed endothelial cells while the contribution from astrocytes
was not significant, supporting our in vivo observations
that endothelial cell interactions with melanoma are key to
governing metastasis. We compared the transcriptomes of in vivo
regeneration-potentiated melanoma cells with in vitro melanoma
cells exposed to supernatant from OGD-exposed astrocytes and
endothelial cells. In vivo regeneration-potentiated metastatic cells
showed greater overlap in transcriptional profile with metastatic
melanoma exposed to OGD-endothelial cell supernatants than
cells exposed to OGD-astrocyte supernatant, suggesting that
endothelial cells are the pivotal cell type in guiding regenerative-
metastatic signaling. This parallels the central role of vasculature
noted above in governing metastatic cell localization to the
regenerative neurovascular niche.
We identified molecular interactomes between secreted
and extracellular proteins from the endothelial cells and
astrocytes to those on in vivo regeneration-potentiated melanoma
cells. These include both established (IL23, IL17A) and
novel (DPP4, CST3) candidates for signaling in metastasis.
Molecular pathway analysis reveals central genes expressed by
melanoma cells that might serve as hubs in organizing the
pro-metastatic molecular response in regeneration-potentiated
melanoma, such as APP, SMAD3, and RPTOR, supporting the
hypothesis that stroke induces pro-metastatic alterations to the
melanoma transcriptome.
CONCLUSION
These studies demonstrate that (a) the regenerative
neurovascular niche enhances metastasis by facilitating
melanoma interactions with regenerative neurovascular
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FIGURE 13 | Unique molecular signaling systems in brain metastasis. (A) Schematic representation of brain and distant sites of metastasis compared. The
significant and differentially expressed genes between Brain metastasis (stroke responsive metastatic cells) and distant metastasis (liver metastasis) were compared.
(B) Unique extracellular and plasma membrane genes that interact with the surrounding niche in each of these two transcriptomes were identified at FPKM
values > 4. (C) Top canonical pathways differentially regulated in brain metastatic melanoma over a distant metastatic site (liver) with the largest negative logP values
are shown. The dashed line represents the ratio of the number of molecules in the dataset over the number of molecules in the pathway. (D,E) GSEA of hallmark
genes up and downregulated in the differentially expressed genes of brain metastatic vs. liver metastasis.
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niche components, (b) regeneration-potentiated melanoma
cells display a unique transcriptome with an enhancement
of genes conducive to metastasis, (c) mimicking repair such
as stroke-like conditions successfully enhances metastasis
while allowing for the identification of cell-specific signaling
molecules that play important roles in driving metastasis.
These molecular targets may allow promotion of recovery
after stroke and brain disease without affecting cancer-
related mechanisms.
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